Uppshot Life Sciences
Uppshot Global is a next-generation diagnostics and devices company focused on innovating genomics, advancing precision medicine, and transforming healthcare. They utilize AI to predict chronic diseases and prevent risk factors, moving healthcare from a reactive to a proactive model. Their solutions involve data privacy, predictive models, preventive actions, and measuring outcomes. They offer services in healthcare consulting, genetic risk factors analysis, and automated prior authorizations with high accuracy. Uppshot Global also develops biomedical devices, including a mental wellness app (HopeLine), an AI diagnostic device (Amby AI), a breast health device (Mammy), a cardiology device (Cardi C), and a pediatric dialysis device. They emphasize personalized healthcare tailored to an individual's unique genetic makeup, lifestyle, and environment.
Uppshot Life Sciences
Uppshot Global is a next-generation diagnostics and devices company focused on innovating genomics, advancing precision medicine, and transforming healthcare. They utilize AI to predict chronic diseases and prevent risk factors, moving healthcare from a reactive to a proactive model. Their solutions involve data privacy, predictive models, preventive actions, and measuring outcomes. They offer services in healthcare consulting, genetic risk factors analysis, and automated prior authorizations with high accuracy. Uppshot Global also develops biomedical devices, including a mental wellness app (HopeLine), an AI diagnostic device (Amby AI), a breast health device (Mammy), a cardiology device (Cardi C), and a pediatric dialysis device. They emphasize personalized healthcare tailored to an individual's unique genetic makeup, lifestyle, and environment.